Intensity-modulated radiation therapy use in the U.S., 2004

Cancer

Volumn 104, Issue 6, 2005, Pages 1296-1303

  Mell, Loren K ^a,b   Mehrotra, Amit K ^a   Mundt, Arno J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Intensity modulated radiation therapy; Physician education; Standardized guidelines; Survey

Indexed keywords

CANCER RADIOTHERAPY; ECONOMIC ASPECT; FEMALE; HEAD AND NECK TUMOR; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MEDICAL EDUCATION; NORMAL HUMAN; ONCOLOGY; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; RISK BENEFIT ANALYSIS; STANDARDIZATION; TREATMENT PLANNING; UNITED STATES; UROGENITAL TRACT TUMOR;

FEMALE; HUMANS; MALE; NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TIME FACTORS; UNITED STATES;

EID: 24644465503     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21284     Document Type: Review

References (40)

1. Leibel SA, Fuks Z, Zelefsky MJ, et al. Intensity-modulated radiotherapy. Cancer J. 2002;8:164-176.
2. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:329-337.
3. Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys. 2000;48:1559-1568.
4. Liu HH, Wang X, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1268-1279.
5. Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2000;48:1613-1621.
6. Lujan AE, Mundt AJ, Yamada SD, Rotmensch J, Roeske JC. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:516-521.
7. Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1258-1267.
8. Ahmed RS, Kim RY, Duan J, Meleth S, De Los Santos JF, Fiveash JB. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys. 2004;60:505-512.
9. Nutting CM, Corbishley CM, Sanchez-Nieto B, Cosgrove VP, Webb S, Dearnaley DP. Potential improvements in the therapeutic ratio for prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol. 2002;75:151-161.
10. Huang E, Teh BS, Strother DR, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys. 2002;52:599-605.
11. Uy NW, Woo SY, Teh BS, et al. Intensity-modulated radiation therapy (IMRT) for meningioma. Int J Radiat Oncol Biol Phys. 2002;53:1265-1270.
12. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695-704.
13. Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001;61:275-280.
14. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:1336-1344.
15. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 2003;56:1354-1360.
16. Hong L, Alektiar KM, Hunt M, Venkatraman E, Leibel SA. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int J Radiat Oncol Biol Phys. 2004;59:752-759.
17. Milano MT, Chmura SJ, Garofalo MC, et al. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys. 2004;59:445-453.
18. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002;53:1111-1116.
19. Kupelian PA, Reddy CA, Carlson TP, Altsman KA, Willoughby TR. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2002;53:904-912.
20. Pirzkall A, Debus J, Haering P, et al. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. Int J Radiat Oncol Biol Phys. 2003;55:362-372.
21. Dawson LA, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46:1117-1126.
22. Forster KM, Smythe WR, Starkschall G, et al. Intensity modulated radiation therapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys. 2003;55:606-616.
23. Knab BR, Roeske JC, Mehta N, et al. Outcome of endometrial cancer patients treated with adjuvant intensity modulated pelvic radiation therapy [abstract]. Int J Radiat Oncol Biol Phys. 2004;60(Suppl 1):S303.
24. Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus I. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55:162-167.
25. Lu TX, Mai WY, Teh BS, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:682-687.
26. Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003;69:227-236.
27. Mell LK, Fyles A, Small W, et al. Adjuvant intensity modulated pelvic radiation therapy in gynecologic malignancies: survey of the Gynecologic IMRT Working Group [abstract]. Int J Radiat Oncol Biol Phys. 2004;60:S215-S216.
28. Gierga DP, Chen GT, Kung JH, Betke M, Lombardi J, Willett CG. Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. Int J Radiat Oncol Biol Phys. 2004;58:1584-1595.
29. Konski AA, Watkins-Bruner D, Feigenburg S, et al. Intensity modulated radiation therapy (IMRT) is a cost effective treatment for intermediate risk prostate cancer [abstract]. Int J Radiat Oncol Biol Phys. 2004;60(Suppl 1):S144.
30. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56:83-88.
31. Mell LK, Roeske JC, Mundt AJ. A survey of intensity modulated radiation therapy use in the United States. Cancer. 2003;98:204-211.
32. Brick JM, Kalton G. Handling missing data in survey research. Stat Methods Med Res. 1996;5:215-238.
33. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312-321.
34. Brixey CJ, Roeske JC, Lujan AE, Yamada SD, Rotmensch J, Mundt AJ. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;54:1388-1396.
35. Szerlag C, Canovas L. Billing and reimbursement issues. In: Mundt AJ, Roeske JC, editors. Intensity modulated radiation therapy: a clinical perspective. Toronto: BC Decker, 2005: 214-229.
36. Brown E. "Cancer in the crosshairs." Forbes. 2002;170:361-364.
37. Schomas D, Milano M, Roeske JC, Mell LK, Mundt AJ. Intensity modulated radiation therapy and the Internet: evaluation of the content and quality of patient-oriented information. Cancer. 2004;101:412-420.
38. Chmura SI, Garofalo M, Salama J, et al. Does the dose protraction inherent to IMRT decrease tumor cell killing in vitro [abstract]? Int J Radiat Oncol Biol Phys. 2004;60(Suppl 1):1107.
39. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys. 2002;51:880-914.
40. Malik R, Oh JL, Roeske JC, et al. Resident education in intensity modulated radiation therapy (IMRT) [abstract]. Int J Radiat Oncol Biol Phys. 2004;60(Suppl 1):S146.